Despite these issues, its popularity on Apple's platform raises questions about China's growing influence in the AI sector and whether the US is lagging in technology leadership. The situation has ...

In its latest research paper, Google DeepMind introduced the concept of “Mind Evolution,” a technique that optimizes responses of large language models (LLMs) for planning and reasoning tasks.

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World ...

Players in Detroit have lauded Johnson’s forward and demanding leadership style, something the Bears hope to tap into. Said Poles: “Meeting with Ben and gaining an understanding of his process ...

Future of AI and science discussed by Google DeepMind CEO While the potential benefits of AI in science have been spoken about, the CEO of Google DeepMind also addressed the potential timeline of ...

Researchers from Google DeepMind, UC San Diego, and the University of Alberta introduced Mind Evolution, an evolutionary search strategy designed to enhance inference-time computation for LLMs. Unlike ...

They've also improved how well the model's thinking process lines up with its final responses. Google DeepMind's CEO Demis Hassabis says this progress builds on more than ten years of work with AI ...

I sat down with Lila Ibrahim, who joined DeepMind, Google’s “engine room of innovation” in 2018, to discuss the promise of AI for scientific discovery among other areas. This interview has ...

(Bloomberg) — Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief ...

By avoiding challenges—such as public speaking, taking on leadership roles, or learning a new skill—we miss out on opportunities for growth and development that lie just beyond our current ...

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive officer. “We’ll ...

Update: The story was updated with Isomorphic declining to comment. Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg ...